Abrdn PLC Arcutis Biotherapeutics, Inc. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Abrdn PLC holds 675,034 shares of ARQT stock, worth $9.53 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
675,034
Previous 587,540
14.89%
Holding current value
$9.53 Million
Previous $9.19 Million
2.98%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ARQT
# of Institutions
252Shares Held
126MCall Options Held
605KPut Options Held
170K-
Suvretta Capital Management, LLC New York, NY11.4MShares$161 Million7.82% of portfolio
-
Jennison Associates LLC11.1MShares$157 Million0.09% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$155 Million4.91% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$124 Million8.65% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$122 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $850M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...